Chi Sheng Pharma & Biotech Co., Ltd (TPEX: 4111)
Health Care · Pharmaceuticals · TW
NT$29.00
+1.05% today · -4.0% 1Y
Chi Sheng Pharma & Biotech Co., Ltd (TPEX: 4111) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $54.27M and employs 80 people.
Over the last twelve months the share price has lost 4.0%, trading between 28.40 and 30.95.
Tweenvest scores Chi Sheng Pharma & Biotech Co., Ltd across four factors: quality 81/100, value 76/100, growth 82/100, dividend 100/100. Its strongest factor is dividend.
4111 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $54.27M
- Revenue (TTM)
- $44.66M
- P/E
- 9.27
- EPS
- 3.13
- Dividend yield
- 4.48%
- Beta (5Y)
- 0.20
- 52-week high
- NT$30.95
- 52-week low
- NT$28.40
- Avg volume (3M)
- —
- Shares outstanding
- 59.83M
- Employees
- 80
- Next earnings
- —
About Chi Sheng Pharma & Biotech Co., Ltd
Chi Sheng Pharma & Biotech Co., Ltd. is a Taiwan-based company actively engaged in the development, production, distribution, and international trade of a diverse range of products. Operating across both domestic and global markets, the company specializes in pharmaceuticals, medical products, cosmetics, health foods, and medical equipment. Its extensive product portfolio covers numerous therapeutic categories, including antibiotics, chemotherapeutic agents, plasma substitutes, amino acid preparations, water nutrients, electrolyte solutions, and vitamins. Additionally, the company provides hepatotropic agents, hormones, adrenal cortical steroids, autonomic nerve agents, antihistamines, antipruritics, antipyretics, analgesics, antitussives, anti-asthmatics, gastro-intestinal preparations, and local anesthetic solutions. Further extending its offerings, Chi Sheng Pharma & Biotech supplies hemodialysis concentrates, peritoneal dialysis solutions, and various other specialized medical items. Beyond medicinal products, the company provides medical devices, fat emulsion products, anesthetics, hemostatic solutions, food products, functional beverages, skincare items, and veterinary medicines. It also offers external solutions such as those for contact lenses, saline, and iodine. The company was founded in 1962 and maintains its headquarters in Hsinchu, Taiwan.
- ISIN
- TW0004111000
- Founded
- 1962
- Listed since
- Dec 31, 2007
- Exchange
- Taipei Exchange
- Currency
- TWD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Talphera, Inc.NasdaqCM: TLPH | $56.06M | $1.08 | -4.42% |
| Eloxx Pharmaceuticals, Inc.NasdaqCM: ELOX | $55.46M | $13.74 | -11.41% |
| K Pharma,Inc.TSE: 4896 | $55.27M | ¥753.00 | +0.40% |
| Sinil Pharmaceutical Co., Ltd.KOSDAQ: A012790 | $55.09M | ₩6,510.00 | +0.46% |
| LeonaBio, Inc.NasdaqCM: LONA | $54.17M | $5.75 | +19.29% |
| CTCBIO Inc.KOSDAQ: A060590 | $54.06M | ₩3,040.00 | -1.62% |
| Wai Yuen Tong Medicine Holdings LimitedSEHK: 897 | $53.96M | HK$0.38 | +1.33% |
| Navana Pharmaceuticals PLCDSE: NAVANAPHAR | $53.46M | Tk61.30 | -3.46% |
Figures last refreshed Oct 11, 2026.